The brain’s own cannabis: the endocannabinoid system

Did you know that the brain contains its own set of chemicals that act like chemicals found in cannabis? You may have heard of endorphins (not to be confused with the Australian electronic musician), opiate-like chemicals made by our bodies that help us control pain and feel good after exercise. Well, the body also makes its own cannabis-like chemicals, called endocannabinoids, that help us with everyday functions such as memory and appetite. Continue reading

Schizophrenia and the immune system, an inflammatory topic

Our new study suggests that we can add schizophrenia to the list of diseases containing an immune system element.  As such, this provides a new set of targets for therapeutic interventions in schizophrenia, which in combination with previous treatments can help alleviate the burden of this disease. You can read the paper here, and the media release here. Continue reading

‘Turning down’ voices and ‘turning up’ thinking in schizophrenia

We are calling for volunteers to take part in a new clinical trial that may help people with schizophrenia.

Many people with schizophrenia have residual symptoms in spite of treatment with antipsychotic medication. Auditory hallucinations (‘hearing voices’) are a symptom that is treatment-resistant in 25 to 30% of patients, and cause distress. Continue reading

Emotional control circuitry and schizophrenia

In addition to the ‘classic’ symptoms of psychosis which include delusions and hallucinations, people with schizophrenia often have problems with ‘executive functions’. This is a cognitive system that resides predominantly in the frontal lobes and regulates other cognitive processes. It is typically invoked when automatic processes need to be overruled to produce appropriate goal-directed behaviour. Another domain that is often affected in schizophrenia is emotional processing. Continue reading